US Patent Issued to Peloton Therapeutics on June 17 for "Compositions and methods for inhibiting CD73" (Colorado, California, Texas Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,068, issued on June 17, was assigned to Peloton Therapeutics Inc. (Dallas).

"Compositions and methods for inhibiting CD73" was invented by Bin Wang (Dallas), Hanbiao Yang (San Diego), Karl Bedke (Oceanside, Calif.), James P. Rizzi (Aurora, Colo.), Heli Huang (Foster City, Calif.) and Keshi Wang (Foster City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds that modulate CD73 activity, pharmaceutical compositions containing these compounds, and methods of using these compounds for treating diseases associated with CD73 activity are described herein."

The patent was filed on May 31, 2019, under Application No. 17/056,977.

*For further...